186 related articles for article (PubMed ID: 37864422)
21. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma.
Sun Z; Zhao Y; Wei Y; Ding X; Tan C; Wang C
Front Immunol; 2022; 13():939523. PubMed ID: 36091049
[TBL] [Abstract][Full Text] [Related]
23. Development of a prognostic model for glioblastoma multiforme based on the expression levels of efferocytosis-related genes.
Xu W; Han L; Zhu P; Cheng Y; Chen X
Aging (Albany NY); 2023 Dec; 15(24):15578-15598. PubMed ID: 38159261
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
[TBL] [Abstract][Full Text] [Related]
25. Association Between Diverse Cell Death Patterns Related Gene Signature and Prognosis, Drug Sensitivity, and Immune Microenvironment in Glioblastoma.
Li J; Song Z; Chen Z; Gu J; Cai Y; Zhang L; Wang Z
J Mol Neurosci; 2024 Jan; 74(1):10. PubMed ID: 38214842
[TBL] [Abstract][Full Text] [Related]
26. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
[TBL] [Abstract][Full Text] [Related]
27. Construction and validation of a cuproptosis-related prognostic model for glioblastoma.
Zhang B; Xie L; Liu J; Liu A; He M
Front Immunol; 2023; 14():1082974. PubMed ID: 36814929
[TBL] [Abstract][Full Text] [Related]
28. Histone acetylation gene-based biomarkers as novel markers of the immune microenvironment in glioblastoma.
Yan X; Feng L; Xu Z; Chen W; Yan H; Wu P; Ding C; Zhu X; Lu Y
J Gene Med; 2023 Oct; 25(10):e3511. PubMed ID: 37097165
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
30. A Genomic Instability-Associated Prognostic Signature for Glioblastoma Patients.
Chen X; Tian F; Wu Z
World Neurosurg; 2022 Nov; 167():e515-e526. PubMed ID: 35977679
[TBL] [Abstract][Full Text] [Related]
31.
Liang L; Yan B; Liu Y; Jiang S; He H; Huang J; Liu W; Xie L
Dis Markers; 2022; 2022():4534080. PubMed ID: 35401877
[TBL] [Abstract][Full Text] [Related]
32. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of single-cell sequencing and weighted co-expression network identifies a novel signature based on cellular senescence-related genes to predict prognosis in glioblastoma.
Bao Q; Yu X; Qi X
Environ Toxicol; 2024 Feb; 39(2):643-656. PubMed ID: 37565732
[TBL] [Abstract][Full Text] [Related]
34. A Promising Glycolysis- and Immune-Related Prognostic Signature for Glioblastoma.
Wang F; Liu X; Jiang H; Chen B
World Neurosurg; 2022 May; 161():e363-e375. PubMed ID: 35144031
[TBL] [Abstract][Full Text] [Related]
35. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
[TBL] [Abstract][Full Text] [Related]
36. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
37. Prognosis and Immune Landscapes in Glioblastoma Based on Gene-Signature Related to Reactive-Oxygen-Species.
Kaushal P; Zhu J; Wan Z; Chen H; Ye J; Luo C
Neuromolecular Med; 2023 Mar; 25(1):102-119. PubMed ID: 35779207
[TBL] [Abstract][Full Text] [Related]
38. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
39. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
[TBL] [Abstract][Full Text] [Related]
40. An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer.
Qi X; Fu Y; Zhang M; Lu C; Wang Y; Peng J; Li G
Biomed Res Int; 2020; 2020():8882576. PubMed ID: 33224983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
